{"product_id":"global-label-free-array-systems-market-size-study-forecast-by-technology-surface-plasmon-resonance-bio-layer-interferometry-cellular-dielectric-spectroscopy-and-other-technologies-application-drug-discovery-protein-interface-analysis-antibody","title":"Global Label-free Array Systems Market Size study \u0026 Forecast, by Technology (Surface Plasmon Resonance, Bio-layer Interferometry, Cellular Dielectric Spectroscopy, and Other Technologies), Application (Drug Discovery, Protein Interface Analysis, Antibody","description":"\u003cp\u003eGlobal Label-free Array Systems Market Size study \u0026amp; Forecast, by Technology (Surface Plasmon Resonance, Bio-layer Interferometry, Cellular Dielectric Spectroscopy, and Other Technologies), Application (Drug Discovery, Protein Interface Analysis, Antibody Characterization and Development, Protein Complex and Cascade Analysis, Other Applications), End User (Contract Research Organizations, Agricultural Research Institutes, R\u0026amp;D Laboratories, Other End Users), and Regional Analysis, 2022-2029\u003c\/p\u003e\n\n\u003cp\u003eThe global Label-free Array Systems Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Label-free Array Systems are used in the drug discovery process. It works on the principle of impedance-based assays, optical interferometry, refractive index, optical interferometry and for identifying and validating new molecules as possible drug candidates. It effectively reduces the time and cost for drug identification and validation process. The Label-free Array Systems market is expanding because of factors such as the rising awareness towards label detection techniques and increasing spending by pharmaceutical companies in the forecast period\u003c\/p\u003e\n\n\u003cp\u003eAccording to the Statista in 2021, the pharmaceutical market is anticipated to generate revenue of around USD 148.00 billion in 2023. Also, the spending towards medicines, pharmaceutical drugs is rising. Also according to the Statista in 2021, around USD 1.42 trillion were spent on medicines. By 2026, the spending towards medicines is expected to reach around USD 1.8 trillion. Whereas rising technological advancement in label free technologies and growing R\u0026amp;D activities by market players create lucrative opportunities for the market. However, higher instrumentation costs hamper the market growth throughout the forecast period of 2022-2029.\u003c\/p\u003e\n\n\u003cp\u003eThe key regions considered for the Global Label-free Array Systems Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing prevalence of chronic disorders and growing drug discovery trials. Also, the Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as increasing demand for label free array system and growing R\u0026amp;D activities by market players\u003c\/p\u003e\n\n\u003cp\u003eMajor market players included in this report are:\u003cbr\u003e\nCorning Incorporated\u003cbr\u003e\nGE Healthcare\u003cbr\u003e\nBruker Corporation\u003cbr\u003e\nBio-rad Laboratories\u003cbr\u003e\nEppendorf AG\u003cbr\u003e\nFluiditic Analytics\u003cbr\u003e\nThermoFisher Scientific\u003cbr\u003e\nShimadzu Corporation\u003cbr\u003e\nDanaher Corporation (Molecular Devices LLC - FORTEBIO)\u003cbr\u003e\nPerkinElmer\u003c\/p\u003e\n\n\u003cp\u003eRecent Developments in the Market:\u003cbr\u003e\n? In June 2018, Bruker has acquired Sierra Sensors GmbH of Germany. Sierra creates cutting-edge analytical biosensors based on surface plasmon resonance (SPR) detection. Sierra instruments, which are powered by patented technologies in the fields of SPR detection and microfluidic sample delivery, are setting a new standard in high-throughput and high-performance label-free analysis.\u003cbr\u003e\n? In November 2018, Agilent Technologies, Inc. (Agilent) purchased ACEA Biosciences, Inc. (ACEA) to expand its label-free array system portfolio.\u003cbr\u003e\nGlobal Label-free Array Systems Market Report Scope:\u003cbr\u003e\nHistorical Data 2019-2020-2021\u003cbr\u003e\nBase Year for Estimation 2021\u003cbr\u003e\nForecast period 2022-2029\u003cbr\u003e\nReport Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends\u003cbr\u003e\nSegments Covered Technology, Application, End-user, Region\u003cbr\u003e\nRegional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World\u003cbr\u003e\nCustomization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional \u0026amp; segment scope*\u003c\/p\u003e\n\n\u003cp\u003eThe objective of the study is to define market sizes of different segments \u0026amp; countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.\u003c\/p\u003e\n\n\u003cp\u003eThe report also caters detailed information about the crucial aspects such as driving factors \u0026amp; challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.\u003c\/p\u003e\n\n\u003cp\u003eThe detailed segments and sub-segment of the market are explained below:\u003cbr\u003e\nBy Technology:\u003cbr\u003e\nSurface Plasmon Resonance\u003cbr\u003e\nBio Layer Interferometry\u003cbr\u003e\nCellular Dielectric Spectroscopy\u003cbr\u003e\nOther Technologies\u003c\/p\u003e\n\n\u003cp\u003eBy Application:\u003cbr\u003e\nDrug Discovery\u003cbr\u003e\nProtein Interface Analysis\u003cbr\u003e\nAntibody Characterization and Development\u003cbr\u003e\nProtein Complex and Cascade Analysis\u003cbr\u003e\nOther Applications\u003c\/p\u003e\n\n\u003cp\u003eBy End-User:\u003cbr\u003e\nContract Research Organizations\u003cbr\u003e\nAgricultural Research Institutes\u003cbr\u003e\nR\u0026amp;D Laboratories\u003cbr\u003e\nOther End Users\u003c\/p\u003e\n\n\u003cp\u003eBy Region:\u003cbr\u003e\nNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003cbr\u003e\nEurope\u003cbr\u003e\nUK\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nROE\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nIndia\u003cbr\u003e\nJapan\u003cbr\u003e\nAustralia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRoAPAC\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nRest of the World\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003c\/p\u003e\n\n\u003cp\u003eCorning Incorporated\u003cbr\u003e\nGE Healthcare\u003cbr\u003e\nBruker Corporation\u003cbr\u003e\nBio-rad Laboratories\u003cbr\u003e\nEppendorf AG\u003cbr\u003e\nFluiditic Analytics\u003cbr\u003e\nThermoFisher Scientific\u003cbr\u003e\nShimadzu Corporation\u003cbr\u003e\nDanaher Corporation (Molecular Devices LLC - FORTEBIO)\u003cbr\u003e\nPerkinElmer\u003c\/p\u003e\n\n\u003cp\u003ePlease note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 200 Pages \/ MCW16227941","offer_id":47646803525938,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-label-free-array-systems-market-size-study-forecast-by-technology-surface-plasmon-resonance-bio-layer-interferometry-cellular-dielectric-spectroscopy-and-other-technologies-application-drug-discovery-protein-interface-analysis-antibody","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}